NO933555L - Atp-analoger - Google Patents

Atp-analoger

Info

Publication number
NO933555L
NO933555L NO93933555A NO933555A NO933555L NO 933555 L NO933555 L NO 933555L NO 93933555 A NO93933555 A NO 93933555A NO 933555 A NO933555 A NO 933555A NO 933555 L NO933555 L NO 933555L
Authority
NO
Norway
Prior art keywords
alkyl
alkoxy
halogen
cr3r4
aryl
Prior art date
Application number
NO93933555A
Other languages
English (en)
Norwegian (no)
Other versions
NO933555D0 (no
Inventor
Anthony Howard Ingall
Peter Alan Cage
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919107236A external-priority patent/GB9107236D0/en
Priority claimed from GB919123671A external-priority patent/GB9123671D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of NO933555D0 publication Critical patent/NO933555D0/no
Publication of NO933555L publication Critical patent/NO933555L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3821—Acyclic saturated acids which can have further substituents on alkyl substituted by B, Si, P or a metal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicinal Preparation (AREA)
  • Color Television Image Signal Generators (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO93933555A 1991-04-06 1993-10-05 Atp-analoger NO933555L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919107236A GB9107236D0 (en) 1991-04-06 1991-04-06 Compounds
GB919123671A GB9123671D0 (en) 1991-11-07 1991-11-07 Compounds
PCT/GB1992/000590 WO1992017488A1 (en) 1991-04-06 1992-04-02 Atp analogues

Publications (2)

Publication Number Publication Date
NO933555D0 NO933555D0 (no) 1993-10-05
NO933555L true NO933555L (no) 1993-10-05

Family

ID=26298696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93933555A NO933555L (no) 1991-04-06 1993-10-05 Atp-analoger

Country Status (18)

Country Link
EP (2) EP0579643A1 (de)
JP (1) JP3141028B2 (de)
CN (2) CN1031879C (de)
AT (1) ATE127808T1 (de)
CA (1) CA2107667A1 (de)
DE (1) DE69204717T2 (de)
DK (1) DK0508687T3 (de)
ES (1) ES2078654T3 (de)
FI (1) FI934366A7 (de)
GR (1) GR3018307T3 (de)
HU (2) HUT64967A (de)
IE (1) IE921091A1 (de)
IL (1) IL101485A0 (de)
MX (1) MX9201577A (de)
NO (1) NO933555L (de)
NZ (1) NZ242243A (de)
PL (1) PL297372A1 (de)
WO (1) WO1992017488A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760021A (en) * 1992-05-29 1998-06-02 The Procter & Gamble Company Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
US5731299A (en) * 1992-05-29 1998-03-24 The Procter & Gamble Company Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
DK0683789T3 (da) 1993-02-10 1998-02-09 Astra Pharma Prod N-alkyl-2-substituerede ATP-analoger
FR2721929B1 (fr) * 1994-06-30 1996-12-20 Centre Nat Rech Scient Analogues stables, non hydrolysables, de diphosphates et leurs procedes de preparation
AU5584698A (en) * 1996-10-30 1998-05-22 University Of North Carolina At Chapel Hill, The P2y receptor antagonists
US6159952A (en) * 1996-11-07 2000-12-12 Inspire Pharmaceuticals, Inc. Method of treating bronchitis with uridine triphosphate and related compounds
US6686462B2 (en) * 1997-02-28 2004-02-03 The Regents Of The University Of California Antiviral compounds and methods of administration
FI104901B (fi) 1997-10-20 2000-04-28 Leiras Oy Uudet metyleenibisfosfonihappojohdannaiset
US6667306B1 (en) 1998-01-15 2003-12-23 Millennium Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
BR0011853A (pt) * 1999-06-22 2002-04-30 Cv Therapeutics Inc Agonistas de receptor a2a de tiofeno
SE9903290D0 (sv) * 1999-09-15 1999-09-15 Astra Pharma Prod Novel compounds
SE9904377D0 (sv) * 1999-12-01 1999-12-01 Astra Pharma Prod Pharmaceutical combinations
GB0013488D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Chemical compound
US7115585B2 (en) 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US7452870B2 (en) 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7132408B2 (en) 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7435724B2 (en) 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
SE0401001D0 (sv) 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process
WO2007107598A1 (en) * 2006-03-21 2007-09-27 Heinrich-Heine-Universität Düsseldorf Phosphorylated a2a receptor agonists
WO2012100654A1 (zh) 2011-01-26 2012-08-02 北京化工大学 呋喃核糖基嘌呤类化合物及其制备方法和应用
CN102659691B (zh) * 2012-05-23 2014-04-02 山东诚创医药技术开发有限公司 一种4,6-二氯-5-氨基-2-丙硫基嘧啶的制备方法
CN103288748A (zh) * 2013-06-21 2013-09-11 四川铂瑞生物医药有限公司 一种4.6-二氯-5-氨基-2-丙硫基嘧啶的制备方法
CN104003943A (zh) * 2014-05-06 2014-08-27 南通常佑药业科技有限公司 一种替格瑞洛中间体的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2049977A1 (en) * 1989-03-24 1990-09-25 Hirofumi Kitaoka Nootropic agent

Also Published As

Publication number Publication date
NO933555D0 (no) 1993-10-05
HU9302812D0 (en) 1993-12-28
FI934366L (fi) 1993-10-05
NZ242243A (en) 1993-06-25
WO1992017488A1 (en) 1992-10-15
CN1120936A (zh) 1996-04-24
JPH06505987A (ja) 1994-07-07
DK0508687T3 (da) 1996-02-05
MX9201577A (es) 1992-10-01
IL101485A0 (en) 1992-12-30
HUT64967A (en) 1994-03-28
HU211334A9 (en) 1995-11-28
CN1031879C (zh) 1996-05-29
JP3141028B2 (ja) 2001-03-05
DE69204717T2 (de) 1996-04-25
IE921091A1 (en) 1992-10-07
CA2107667A1 (en) 1992-10-07
CN1068574A (zh) 1993-02-03
AU1451992A (en) 1992-11-02
ATE127808T1 (de) 1995-09-15
EP0508687A1 (de) 1992-10-14
EP0508687B1 (de) 1995-09-13
PL297372A1 (en) 1993-09-06
DE69204717D1 (de) 1995-10-19
FI934366A0 (fi) 1993-10-05
EP0579643A1 (de) 1994-01-26
ES2078654T3 (es) 1995-12-16
GR3018307T3 (en) 1996-03-31
FI934366A7 (fi) 1993-10-05
AU648885B2 (en) 1994-05-05

Similar Documents

Publication Publication Date Title
NO933555L (no) Atp-analoger
DK114783A (da) Hidtil ukendte forbindelser, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
JPS568361A (en) Pyroglutamic acid derivative and analogue
DK0625977T3 (da) Piperazinderivater som 5-1A-antagonister
ES474215A1 (es) Procedimiento para la preparacion de derivados imidazolile- tiloxialcoxilicos y sus analogos con agrupacion tio
DK538886D0 (da) 3-oxadiazol- og 3-carbonsyre-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
SE8101464L (sv) 2-penem-3-karboxylsyraderivat, deras framstellning och anvendning
ES466366A1 (es) Un procedimiento para preparar derivados de metasulfonamido-benzamida.
SE8305160L (sv) Antibakteriella emnen
NO167746C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive muramylpeptidderivater.
NO921159D0 (no) Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer
AU4271389A (en) Phenylalkyl or phenylalkoxyethyl substituted piperazine derivatives
ES8103056A1 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ATE6652T1 (de) Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DK48188A (da) Ergolinyl-heterocycliske forbindelser og fremgangsmaade til fremstilling deraf
SE7412163L (de)
ES8300772A1 (es) Un procedimiento para la preparacion de derivados de penici-lina.
ES8304574A1 (es) Un procedimiento para la preparacion de nuevos derivados de penicilina.
DE2963724D1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
NO960017L (no) Nye pseudopeptider med trifluormetylsubstituert 2-azabicyklooktan
ES8301482A1 (es) Un procedimiento para la preparacion de un derivado del aci-do clavulanico
ES438236A1 (es) Un procedimiento para la preparacion de eteres fenil (susti-tuido)-alquilicos sustituidos.